Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes
Open Access
- 25 April 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 51 (7), 1115-1122
- https://doi.org/10.1007/s00125-008-1009-9
Abstract
Aims/hypothesis Pregnancy is characterised by temporarily increased insulin resistance. Gestational diabetes occurs when pancreatic beta cell function is unable to compensate for this insulin resistance. Retinol-binding protein 4 (RBP4) could be related to insulin resistance. We hypothesised that RBP4 is elevated in gestational diabetes. Methods Serum RBP4, transthyretin and retinol were cross-sectionally measured in 42 women with gestational diabetes and 45 pregnant controls. Of these, 20 women with and 22 without gestational diabetes were included in an additional longitudinal study. RBP4 was determined by enzyme immunometric assay (EIA) and western blot. Results Women with gestational diabetes had lower RBP4 EIA and western blot levels than controls (median 6.8 [interquartile range, 3.9–14.3] vs 11.3 [7.8–19.9] μg/ml, p < 0.001 and 25.1 [21.7–29.6] vs 26.6 [23.5–32.2] μg/ml, p = 0.026). Transthyretin and the RBP4:transthyretin molar ratio were comparable between the groups. Serum retinol was lower (p < 0.001) and the RBP4 Western blot level: retinol molar ratio was higher in women with gestational diabetes (p = 0.044). RBP4 was not associated with the glucose or homeostasis model assessment of insulin resistance (HOMA-IR), but in gestational diabetes the RBP4:retinol molar ratio correlated with blood glucose and negatively with 2 h post-load insulin. The RBP4:transthyretin ratio correlated with HOMA-IR and fasting insulin in controls. In women with gestational diabetes RBP4 EIA and western blot levels increased after delivery. Retinol increased in both groups, while transthyretin and the RBP4:transthyretin ratio were not altered after parturition. Conclusions/interpretation RBP4 measured by two different techniques is not elevated, but the RBP4:retinol molar ratio is higher and correlates with fasting blood glucose in women with gestational diabetes. Thus, the RBP4:retinol ratio and the RBP4:transthyretin ratio are more informative than RBP4 levels alone when assessing insulin–glucose homeostasis during pregnancy.Keywords
This publication has 47 references indexed in Scilit:
- Plasma Volume Expansion in Pregnancy: Implications for Biomarkers in Population StudiesCancer Epidemiology, Biomarkers & Prevention, 2007
- Retinaldehyde represses adipogenesis and diet-induced obesityNature Medicine, 2007
- Retinol-Binding Protein 4 in Human ObesityDiabetes, 2006
- Pregnancy and Insulin ResistanceMetabolic Syndrome and Related Disorders, 2006
- Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitusGynecological Endocrinology, 2006
- Gestational diabetes mellitus and the risk of metabolic syndrome: a population-based study in Lausanne, SwitzerlandDiabetes & Metabolism, 2005
- Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetesNature, 2005
- Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study.Journal of Clinical Pathology, 1996
- Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transportersDiabetes, 1993
- Changes in plasma vitamin A in lactating and non‐lactating oral contraceptive usersBJOG: An International Journal of Obstetrics and Gynaecology, 1983